Dr. David Neff has been involved with large scale planning programs to address population health related issues in the areas of cardiovascular disease, diabetes management and opioid addiction since 2000. He has been studying the Opioid Mortality Crisis since 2010 and has been a member of the Michigan Osteopathic Association’s Presidential Ad Hoc Committee to address the crisis since it was formed in February, 2015. He has been instrumental in developing the MOA’s two-pronged strategy of addressing the crisis with 1) activating its own membership and 2) working closely in a crossfunctional manner with key stakeholder groups across Michigan. The initiative was recently recognized by the Michigan Society of Association Executives with the Diamond Achievement Award for Best Governmental Relations Project on combating the opioid crisis through provider education programs, conducting a Town Hall event with key members of the Governor’s Task Force, it’s leadership on legislation and raising awareness through newsletters and social media.
Dr. Neff is currently a fulltime consultant for Office of Medical Affairs within the Medical Services Administration in the Michigan Department of Health and Human Services after retiring from Merck and Company in 2014 as a Strategy Leader in Global Medical Affairs. He actively sees patients including those with recalcitrant chronic pain and/or opioid addiction. Dr. Neff attended Michigan State University in East Lansing, Michigan, where he graduated with a Bachelor of Science degree in physiology in 1976. Additional post graduate studies included lipid biochemistry, neuroscience & systems science. He graduated from the Michigan State University College of Osteopathic Medicine (MSUCOM) in 1980. He completed an undergraduate fellowship in Clinical Biomechanics and Osteopathic Manual Medicine. He has been on the clinical faculty at MSUCOM in the Department of Family and Community Medicine since 1981. He is board certified in Family Medicine. He is former Director of Pharmaceutical Studies in the Office of Research at Michigan State University. Since his retirement from Merck, he still retains an active research interest in cardiovascular genomics and bioinformatics. He has been a member of the American Osteopathic Association (AOA), the American College of Osteopathic Family Physicians (ACOFP), the American Osteopathic Association of Addiction Medicine (AOAAM), the American Heart Association (AHA), the American Diabetes Association (ADA), the National Lipid Association (NLA), the American Society for Quality (ASQ), the American Medical Informatics Association (AMIA) and the American Osteopathic Association of Medical Informatics (AOAMI).